Drawing for TECMED MEDICAL TECHNOLOGY

USPTO serial 79419365

TECMED MEDICAL TECHNOLOGY

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
YOO, JEANE
Law office
TMO LAW OFFICE 120

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TECMED MEDICAL TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, medicinal preparations; sanitary products for medicine.SECTION 70 - CANCELLED—
009Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data.SECTION 70 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; orthopedic articles; suture materials; therapeutic and assistance devices designed for people with disabilities; massage apparatus; apparatus, devices and articles for child care; sexual activity apparatus, devices and articles.SECTION 70 - CANCELLED—
035Advertising; commercial business administration, organization and management; office functions.SECTION 70 - CANCELLED—
041Training; entertainment; sporting and cultural activities.SECTION 70 - CANCELLED—
042Medical research.SECTION 70 - CANCELLED—
044Medical services.SECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 19, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 19, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 10, 2025RFNTREFUSAL PROCESSED BY IB—
Oct 3, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 16, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 15, 2025RFRRREFUSAL PROCESSED BY MPU—
Aug 6, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 5, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jun 14, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 13, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jun 13, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2025DOCKASSIGNED TO EXAMINER—
Mar 21, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 21, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 21, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 20, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance